• About us
• Contact

Advertisement

Organisation › Details

LenioBio GmbH

LenioBio is a protein expression platform company committed to the advancement of transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell. LenioBio was established as a legal entity in Germany in September 2016, with offices in Dusseldorf and R&D and production labs in Aachen. *

 

	Start	2019-11-18 established (s-off)
	Predecessor	Fraunhofer-Institut für Molekularbiologie und Angewandte Ökologie IME
	Industry	protein expression technology
	Industry 2	artificial intelligence (AI) / machine learning (ML)
	Person	Martis, Remberto (LenioBio 202203 Managing Director (CEO) + Founder)
	Person 2	Finke, Franziska (LenioBio 202203 CFO)
	Region	Düsseldorf
	Country	Germany
	Street	401 Erkrather Str.
	City	40231 Düsseldorf
	Tel	+49-211-8909-4030-0
		Address record changed: 2022-03-21
Basic data	Employees	n. a.
		* Document for »About Section«: LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf.
		Record changed: 2023-12-30

Advertisement

More documents for LenioBio GmbH

• [1] LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.